Medical Devices
Medical Device NASP O 21 ALPHA-AMYLASE (ASPERGILLUS ORYZAE) - 14-4370-01
The medical device NASP O 21 ALPHA-AMYLASE (ASPERGILLUS ORYZAE) is realized by PHADIA AB
| Trade name | NASP O 21 ALPHA-AMYLASE (ASPERGILLUS ORYZAE) |
| Product Code | 14-4370-01 |
| Manufacturer of the medical device | PHADIA AB |
| Tax code of the producer | 0 |
| Vat Number | 556041320401 |
| Category Name | IMMUNOGLOBULIN E - SPECIFIC, MONOTEST/MONORESULT |
| Category Code | W01020202 |
| Sign repertoire | Registered |
| Group of similar Medical devices | 61630 |
| Medical device reference | 0 |
| Type | Medical Device Class |
| Progressive number assigned to the medical device | 1222055 |
| Effective Date | Wednesday 22 October 2014 |
| End date | End of validity is not present for the medical device |
| End date trade | Medical device still on the market |
| Date of first publication | Wednesday 22 October 2014 |
Della stessa categoria di dispositivi medici:
- FLUID SEMINAL - 14-4371-01
- PALMA REGINA (ARECASTRUM ROMANZOFFIANUM) - 14-4373-01
- AUSTRALIAN PINE (CASUARINA EQUISETIFOLIA) - 14-4374-01
- INSULIN PORCINA (INSULIN PORCINE) - 14-4391-01
- INSULIN BOVINE (INSULIN VEAL) - 14-4392-01
- GLYCYPHAGUS DOMESTICUS (STORAGE MITE) - 14-4393-01
- EPITHELIUM MOUSE - 14-4394-01